Vinay Prasad has been picked as CBER director(X/Vinay Prasad) Prasad now joins the Food and Drug Administration from the University of California at San Francisco, where he served as an ...

On Wednesday 7th May 2025, at 3-4pm, Prof Ralf Seppelt, Director of the Luxembourg Centre for Socio-Environmental Systems, Luxembourg University, will be visiting Tim Newbold and giving a CBER ...

In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics Evaluation and Research (CBER). FDA Commissioner Marty Makary ...

Ray & Mascari Inc. has recalled its 4-count vine-ripe tomatoes, sold in clamshell packaging across 11 states, due to possible salmonella contamination. No illnesses have been reported. The tomatoes ...

This RTF letter was received despite reaching unanimous guidance and encouragement at the in-person January 2025 meeting from the leadership of the Agency, including from CBER, CDER and OCE to ...

Diljit Dosanjh just confirmed that he will be making his Met Gala debut this year. The Punjabi singer shared a note on his Instagram stories, confirming his appearance at the global event. Other ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that ...

Print it. Copy it. Tweak it if you need to. But most of all, use it as a tool for growth. A note about these worksheets, which some may refer to as “PBIS worksheets.” Yes, another special education ...

One quar­ter af­ter Ab­b­Vie raised fu­ture sales es­ti­mates due to the suc­cess­es of its im­munol­o­gy port­fo­lio, the com­pa­ny again saw high­er-than-ex­pect­ed rev­enues … ...

The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The move follows a reconfiguration last year to move into immunology. Caribou ...